COMMUNIQUÉS West-GlobeNewswire

PCI Biotech initiates research collaboration with IMV Inc

24/05/2018 - 14:23

Exploring synergies between PCI and DPX technologies to further enhance the effect of novel oncologic therapies Oslo (Norway) 24 May 2018 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today [...]

Achaogen Announces Multiple Plazomicin Presentations at ASM Microbe 2018 Annual Meeting

24/05/2018 - 14:01

SOUTH SAN FRANCISCO, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]

Allscripts to deliver anesthesia solution across SingHealth healthcare institutions

24/05/2018 - 14:01

CHICAGO, May 24, 2018 (GLOBE NEWSWIRE) -- Singapore’s largest public healthcare group, SingHealth, has partnered with Allscripts (NASDAQ: MDRX ) to implement iPro Anesthesia across the Group. The advanced software which [...]

Vital Therapies Hosting Analyst R&D Day Today

24/05/2018 - 14:01

SAN DIEGO, May 24, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will host a live [...]

U.S. FDA Grants Fast Track Designation for Krystal Biotech’s KB103 for the Treatment of Dystrophic Epidermolysis Bullosa

24/05/2018 - 14:00

PITTSBURGH, May 24, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS ), a gene therapy company developing topical and intradermal "off-the-shelf" treatments for rare dermatological diseases, [...]

Melinta Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference

24/05/2018 - 14:00

NEW HAVEN, Conn., May 24, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]

Enrolment Completed in Cynata’s Phase 1 Clinical Trial of CYP-001 in GvHD

24/05/2018 - 14:00

MELBOURNE, Australia, May 24, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX:CYP) is pleased to announce that the final patient has been treated in [...]

United Rentals and Rahal Letterman Lanigan Racing Continue Support for Veterans Through SoldierStrong and Turns for Troops

24/05/2018 - 14:00

Every Lap IndyCar Drivers Graham Rahal, Oriol Servia, and 2017 Indy 500 Winner Takuma Sato Complete Benefits Veterans STAMFORD, Conn., May 24, 2018 (GLOBE NEWSWIRE) -- SoldierStrong, a nonprofit organization dedicated [...]

Immune Design Announces Launch of Web Portal for SYNOVATE Phase 3 Study of CMB305 Immunotherapy in Synovial Sarcoma

24/05/2018 - 14:00

-- 1 st global Phase 3 trial focused on synovial sarcoma patients -- www.synovatestudy.com SEATTLE and SOUTH SAN FRANCISCO, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ ), an immunotherapy [...]

VBL Therapeutics to Present at Upcoming Conferences in June

24/05/2018 - 14:00

TEL AVIV, Israel, May 24, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Golden Leaf Holdings Hires Ryan Purdy as Vice President of Operations

24/05/2018 - 14:00

PORTLAND, Ore., May 24, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around [...]

Corium to Present at the Jefferies 2018 Global Healthcare Conference

24/05/2018 - 14:00

MENLO PARK, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]

Inovio Boosts Leadership Focused on Partnership and Grant Funding By Appointing Two New VPs for Business Development and R&D

24/05/2018 - 14:00

PLYMOUTH MEETING, Pa., May 24, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that it has bolstered its efforts to attract partnerships and collaborations and increase non-dilutive [...]

ATW Tech Announces an Increase in Its Revenues of 23% for Q1-2018 to Reach $3.4m

24/05/2018 - 14:00

MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- ATW Tech (“AtmanCo” or the “Company”) (TSX-V: ATW ) announces its financial results for its 1st quarter ended March 31, 2018. For its first quarter of 2018, the Company [...]

ATW Tech annonce des revenus en hausse de 23% pour Q1-2018 pour atteindre 3,4m$

24/05/2018 - 14:00

MONTRÉAL, 24 mai 2018 (GLOBE NEWSWIRE) -- ATW Tech (« AtmanCo » ou la « Société ») (TSX-V: ATW ) annonce aujourd'hui ses résultats pour son premier trimestre terminé le 31 mars 2018. Pour son premier trimestre 2018, la [...]

CareDx to Hold Press Conference at American Transplant Congress

24/05/2018 - 14:00

BRISBANE, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]

Adherium Announces Appointment of David Allinson as Chief Financial Officer

24/05/2018 - 14:00

SAN MATEO, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), an award-winning digital health company that improves medication adherence, patient outcomes and engagement, today announced that David Allinson [...]

Progressive Care Begins Development of Proprietary Tele-pharmacy Software for Exclusive Use

24/05/2018 - 14:00

Leading Florida-Based Healthcare Services and Technology Company Expands its Kiosk Program in Florida MIAMI, May 24, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and [...]

Chembio Diagnostics Announces Agreement with Bio-Manguinhos to Commercialize Point-of-Care Tests for Dengue, Zika and Chikungunya in Brazil

24/05/2018 - 14:00

MEDFORD, N.Y., May 24, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today announced the signing of a long-term agreement [...]